FUT8 and prostate carcinoma: Previous studies have suggested that FUT8 can be repressed by androgens [84, 85], and consistent with this, we detected an increase in FUT8 levels in clinical samples from patients treated with ADT and a decrease in FUT8 levels in prostate cancer cells stimulated with androgens (Figure S1C–G).